JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Graff, J.
Right arrow Articles by Kirchmaier, C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Graff, J.
Right arrow Articles by Kirchmaier, C. M.

Vol. 300, Issue 3, 952-957, March 2002

Close Relationship between the Platelet Activation Marker CD62 and the Granular Release of Platelet-Derived Growth Factor

Jochen Graff1, Ute Klinkhardt1, Valérie B. Schini-Kerth, Sebastian Harder, Nicole Franz, Steffen Bassus and Carl M. Kirchmaier

Institute of Clinical Pharmacology, University Hospital, Frankfurt/Main, Germany

The expression of CD62 on the surface of platelets is considered to be an indicator of platelet degranulation and secretion. We characterized the relationship between CD62 expression and platelet-derived growth factor (PDGF)AB and PDGFBB secretion in response to thrombin-receptor activating peptide (TRAP). The principal findings were 1) expression of CD62 as a constituent of platelet alpha -granule membrane and secretion of PDGF, an important ingredient of alpha -granules, can be stimulated by TRAP-induced activation in a dose-dependent fashion; 2) the activation marker and secretion product are closely correlated with each other; and 3) changes in the CD62 expression induced by a drug, namely clopidogrel, or by a disease, namely diabetes, are paralleled by changes in PDGF secretion. Although CD62 is perceived as an activation marker of platelets indicating enhanced aggregability and secretion of alpha -granular content, the proof that the CD62 status and its modifications reflect directly the actual secretion of the most important platelet mitogen, PDGF, has so far not been given. This ex vivo-in vitro study shows that at least for the activation pathway provided by the PAR-1 receptor for which TRAP is the selective agonist, CD62 expression on platelets could be a surrogate for their secretory activity.

1 Contributed equally to this work.

0022-3565/02/3003-0952$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2002 by The American Society for Pharmacology and Experimental Therapeutics


This article has been cited by other articles:


Home page
 CirculationHome page
N. E. Hiemann, E. Wellnhofer, C. Knosalla, H. B. Lehmkuhl, J. Stein, R. Hetzer, and R. Meyer
Prognostic Impact of Microvasculopathy on Survival After Heart Transplantation: Evidence From 9713 Endomyocardial Biopsies
Circulation, September 11, 2007; 116(11): 1274 - 1282.
[Abstract] [Full Text] [PDF]

Home page
 PerfusionHome page
C. W Smith, R. S Binford, D. W Holt, and D. P Webb
Quality assessment of platelet rich plasma during anti-platelet therapy
Perfusion, January 1, 2007; 22(1): 41 - 50.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Abele, M. Weyand, M. Wollin, N. E. Hiemann, F. Harig, T. Fischlein, and S. M. Ensminger
Clopidogrel reduces the development of transplant arteriosclerosis
J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1161 - 1166.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
M. Steinhoff, J. Buddenkotte, V. Shpacovitch, A. Rattenholl, C. Moormann, N. Vergnolle, T. A. Luger, and M. D. Hollenberg
Proteinase-Activated Receptors: Transducers of Proteinase-Mediated Signaling in Inflammation and Immune Response
Endocr. Rev., February 1, 2005; 26(1): 1 - 43.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Schafer, N. J. Alp, S. Cai, C. A. Lygate, S. Neubauer, M. Eigenthaler, J. Bauersachs, and K. M. Channon
Reduced Vascular NO Bioavailability in Diabetes Increases Platelet Activation In Vivo
Arterioscler. Thromb. Vasc. Biol., September 1, 2004; 24(9): 1720 - 1726.
[Abstract] [Full Text] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 2002 by the American Society for Pharmacology and Experimental Therapeutics.